Saved in:
| Main Author: | Badhe, Pravin |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2025
|
| Online Access: | https://doi.org/10.5281/zenodo.17898008 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
In-Vitro Evaluation of ACTB Modulation: Implications for Biomarker Discovery, Drug Response Prediction, and Overcoming Chemoresistance in Breast Cancer Models
by: Badhe, Pravin
Published: (2025)
by: Badhe, Pravin
Published: (2025)
RNA-seq–Based Mechanistic Evaluation of Phytochemicals and Small Molecules in Experimental Cancer Models
by: Badhe, Pravin, et al.
Published: (2026)
by: Badhe, Pravin, et al.
Published: (2026)
Formulation Innovations Targeting ACTB Pathways in Breast Cancer: From Cytoskeletal Dysregulation to Precision Drug Delivery
by: Badhe, Ashwini
Published: (2025)
by: Badhe, Ashwini
Published: (2025)
From Bench to Biomarkers: RNA-seq-Driven Discovery of Chemoprevention Biomarkers in Animal Models
by: Badhe, Ashwini, et al.
Published: (2026)
by: Badhe, Ashwini, et al.
Published: (2026)
In Vitro Validation of Herbal Products: Insights from MTT, ELISA, and Mechanistic Assays
by: Badhe, Pravin
Published: (2025)
by: Badhe, Pravin
Published: (2025)
Pharma Marketing Management
by: Dr. Krishnananda Kamath K, Dr. Pravin Badhe, Tapan Kumar Mahato and Ashwini Badhe
Published: (2025)
by: Dr. Krishnananda Kamath K, Dr. Pravin Badhe, Tapan Kumar Mahato and Ashwini Badhe
Published: (2025)
Cellular and Exosomal MicroRNAs: Emerging Clinical Relevance as Targets for Breast Cancer Diagnosis and Prognosis
by: Faith Mokobi Zablon, et al.
Published: (2024)
by: Faith Mokobi Zablon, et al.
Published: (2024)
Design, Synthesis, Anticancer Evaluation, and EGFR‐Targeted Molecular Docking of Novel 4‐(benzylidenehydrazone)‐3‐nitropyridine Derivatives
by: Mahadevi Vitthal Kendre, et al.
Published: (2026)
by: Mahadevi Vitthal Kendre, et al.
Published: (2026)
Clinical Outcomes of Different Generation EGFR TKIs in Susceptible EGFR ‐Mutated Advanced Nonsmall‐Cell Lung Cancer
by: Chia‐Yu Kuo, et al.
Published: (2025)
by: Chia‐Yu Kuo, et al.
Published: (2025)
Design and Synthesis of New Quinazoline Hybrid Molecules as EGFR Targeting Anti‐Breast Cancer Agents
by: Pandaga Saidulu, et al.
Published: (2026)
by: Pandaga Saidulu, et al.
Published: (2026)
Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
by: Tvisha Devireddy, et al.
Published: (2025)
by: Tvisha Devireddy, et al.
Published: (2025)
LegalSim: Multi-Agent Simulation of Legal Systems for Discovering Procedural Exploits
by: Badhe, Sanket
Published: (2025)
by: Badhe, Sanket
Published: (2025)
ScamAgents: How AI Agents Can Simulate Human-Level Scam Calls
by: Badhe, Sanket
Published: (2025)
by: Badhe, Sanket
Published: (2025)
Targeted Nanoprobes Enabled Precision Theranostics in Triple‐Negative Breast Cancer
by: Ke Ma, et al.
Published: (2025)
by: Ke Ma, et al.
Published: (2025)
Identification and Characterization of Cytokine Genes in Breast Cancer for Predicting Clinical Outcomes
by: Zhifen Han, et al.
Published: (2025)
by: Zhifen Han, et al.
Published: (2025)
Germline Pathogenic Variants and Clinical Outcomes in Asian Patients With Breast Cancer
by: Rui Kitadai, et al.
Published: (2025)
by: Rui Kitadai, et al.
Published: (2025)
Clinical Outcomes of Later‐Generation EGFR ‐ TKIs for Uncommon EGFR Mutations in NSCLC : A Multicenter Real‐World Study
by: Lisa Shigematsu, et al.
Published: (2025)
by: Lisa Shigematsu, et al.
Published: (2025)
Breast Cancer: Targets and Therapy
Published: (2010)
Published: (2010)
Prompt-Level Distillation: A Non-Parametric Alternative to Model Fine-Tuning for Efficient Reasoning
by: Badhe, Sanket, et al.
Published: (2026)
by: Badhe, Sanket, et al.
Published: (2026)
Adaptive MRI With AI‐Guided Triage in Breast Cancer Screening: Clarifying the Terminology, Methodology, and Clinical Relevance
by: Deniz Esin Tekcan Sanli, et al.
Published: (2025)
by: Deniz Esin Tekcan Sanli, et al.
Published: (2025)
Clinical Relevance and Drug Modulation of PPAR Signaling Pathway in Triple‐Negative Breast Cancer: A Comprehensive Analysis
by: Yanxia Zhang, et al.
Published: (2024)
by: Yanxia Zhang, et al.
Published: (2024)
Upregulated SAE1 Drives Tumorigenesis and Is Associated with Poor Clinical Outcomes in Breast Cancer
by: Hong Liu, et al.
Published: (2024)
by: Hong Liu, et al.
Published: (2024)
YIGSR Functionalized Hybrid Exosomes Spatially Target Dasatinib to Laminin Receptors for Precision Therapy in Breast Cancer
by: Pratiksha Tiwari, et al.
Published: (2025)
by: Pratiksha Tiwari, et al.
Published: (2025)
Emerging Nanozyme Strategies for Precision Breast Cancer Treatment
by: Jian Zang, et al.
Published: (2025)
by: Jian Zang, et al.
Published: (2025)
Breast Cancer: Basic and Clinical Research
Published: (2008)
Published: (2008)
Overcoming EGFR‐Mediated Dendritic Cell Dysfunction to Enhance Anti‐tumor Immunity in EGFR‐Mutant NSCLC by Precisely Targeting CD73 With pH‐responsive Nanocarriers
by: Xiaoling Shang, et al.
Published: (2025)
by: Xiaoling Shang, et al.
Published: (2025)
Breast Cancer: Molecular Pathogenesis and Targeted Therapy
by: Md Abdus Samad, et al.
Published: (2025)
by: Md Abdus Samad, et al.
Published: (2025)
Learning a Clinically-Relevant Concept Bottleneck for Lesion Detection in Breast Ultrasound
by: Bunnell, Arianna, et al.
Published: (2024)
by: Bunnell, Arianna, et al.
Published: (2024)
Relevance of the Human Microbiome in Breast Cancer: A Global Bibliometric and Visual Analysis
by: Faqeeha Javed, et al.
Published: (2024)
by: Faqeeha Javed, et al.
Published: (2024)
Better Outcomes for Ovarian Cancer Associated With the Detection of Anti‐EBV TCR CDR3s: Potential Relevance to Diffuse Large B‐Cell Lymphoma
by: Nandini Goel, et al.
Published: (2025)
by: Nandini Goel, et al.
Published: (2025)
The Silent Vote: Improving Zero-Shot LLM Reliability by Aggregating Semantic Neighborhoods
by: Badhe, Sanket, et al.
Published: (2026)
by: Badhe, Sanket, et al.
Published: (2026)
Long-Tail Knowledge in Large Language Models: Taxonomy, Mechanisms, Interventions and Implications
by: Badhe, Sanket, et al.
Published: (2026)
by: Badhe, Sanket, et al.
Published: (2026)
Taxonomy of the Retrieval System Framework: Pitfalls and Paradigms
by: Shah, Deep, et al.
Published: (2026)
by: Shah, Deep, et al.
Published: (2026)
AI ‐Driven Variant Annotation for Precision Oncology in Breast Cancer
by: Kriti Shukla, et al.
Published: (2025)
by: Kriti Shukla, et al.
Published: (2025)
Nanomaterial‐Based Precision Medicine for Breast Cancer Diagnosis and Treatment
by: Tanaka Ndongwe, et al.
Published: (2025)
by: Tanaka Ndongwe, et al.
Published: (2025)
Targeting Transient Receptor Potential Melastatin‐2 (TRPM2) Enhances Therapeutic Efficacy of Third Generation EGFR Inhibitors against EGFR Mutant Lung Cancer
by: Zhen Chen, et al.
Published: (2024)
by: Zhen Chen, et al.
Published: (2024)
Outcomes After Intratumoral Delivery of Immunotherapy in Breast Cancer
by: Camille C. Baumrucker, et al.
Published: (2026)
by: Camille C. Baumrucker, et al.
Published: (2026)
Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
by: Yerim Jin, et al.
Published: (2024)
by: Yerim Jin, et al.
Published: (2024)
Innovative Pyrazole–Thiazole–Oxadiazole Hybrid Compounds for Targeted EGFR/VEGFR2 Inhibition in Cancer Treatment
by: Burak Kuzu, et al.
Published: (2025)
by: Burak Kuzu, et al.
Published: (2025)
EGFR Signaling and Related Pathways: Potential Targets for CRISPR‐Mediated Gene Editing System in the Colorectal Cancer
by: Mobina Tabibian, et al.
Published: (2025)
by: Mobina Tabibian, et al.
Published: (2025)
Similar Items
-
In-Vitro Evaluation of ACTB Modulation: Implications for Biomarker Discovery, Drug Response Prediction, and Overcoming Chemoresistance in Breast Cancer Models
by: Badhe, Pravin
Published: (2025) -
RNA-seq–Based Mechanistic Evaluation of Phytochemicals and Small Molecules in Experimental Cancer Models
by: Badhe, Pravin, et al.
Published: (2026) -
Formulation Innovations Targeting ACTB Pathways in Breast Cancer: From Cytoskeletal Dysregulation to Precision Drug Delivery
by: Badhe, Ashwini
Published: (2025) -
From Bench to Biomarkers: RNA-seq-Driven Discovery of Chemoprevention Biomarkers in Animal Models
by: Badhe, Ashwini, et al.
Published: (2026) -
In Vitro Validation of Herbal Products: Insights from MTT, ELISA, and Mechanistic Assays
by: Badhe, Pravin
Published: (2025)